Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Foenumoside B
Cat. No.:
OB0125LY-038
Appearance:
Solid
Purity:
≥95%
Identity:
Confirmed by NMR.
Size:
Add to basket
Product Overview
Description:
Foenumoside B is a triterpene saponin that inhibits PPARγ-induced adipogenesis.
Synonyms:
877661-00-2; Foenumoside
CAS No.:
877661-00-2
Compound CID:
162936607
Formula:
C60H96O25
Formula Weight:
1217.39
Specification
Source:
Lysimachia foenum-graecum
Target:
AMPK; PPAR
Pathway:
Epigenetics; PI3K/Akt/mTOR; Cell cycle/DNA damage; Vitamin D related/Nuclear receptor
Storage:
Storage at -80°C.
Applications:
Foenumoside B can be used in the study of obesity and obesity-related metabolic diseases.
